Østerrike - tysk - AGES (Agentur für Gesundheit und Ernährungssicherheit)

skin care pharma gmbh - methylprednisolon aceponat -

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

skin care pharma gmbh - methylprednisoloni aceponas - emulsja na skórę - 1 mg/g

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

skin care pharma gmbh - methylprednisoloni aceponas - roztwór na skórę - 1 mg/ml

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

skin care pharma gmbh - metilprednisolona aceponato - soluciÓn cutÁnea - 1 mg/ml - metilprednisolona aceponato 1 mg - metilprednisolona, aceponato de

Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

germed farmaceutica ltda - latanoprosta - prostaglandinas

Østerrike - tysk - AGES (Agentur für Gesundheit und Ernährungssicherheit)

skin care pharma gmbh - methylprednisolon aceponat -

USA - engelsk - NLM (National Library of Medicine)

physicians total care, inc. - isotretinoin (unii: eh28up18if) (isotretinoin - unii:eh28up18if) - isotretinoin 20 mg - severe recalcitrant nodular acne zenatane™ is indicated for the treatment of severe recalcitrant nodular acne. nodules are inflammatory lesions with a diameter of 5 mm or greater. the nodules may become suppurative or hemorrhagic. “severe,” by definition,2 means “many” as opposed to “few or several” nodules. because of significant adverse effects associated with its use, zenatane™ should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. in addition, zenatane™ is indicated only for those female patients who are not pregnant, because zenatane™ can cause severe birth defects (see boxed contraindications and warnings ).  a single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients.1,3,4 if a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience has shown that patients may c

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

aristo pharma gmbh - aceponato de metilprednisolona - solução cutânea - 1 mg/ml - metilprednisolona, aceponato 1 mg/ml - methylprednisolone aceponate - n/a - duração do tratamento: curta ou média duração

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

aristo pharma gmbh - aceponato de metilprednisolona - solução cutânea - 1 mg/ml - metilprednisolona, aceponato 1 mg/ml - methylprednisolone aceponate - n/a - duração do tratamento: curta ou média duração

Irland - engelsk - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - cefuroxime - film coated tablet - 250 milligram